DK1259250T3 - Endoparasiticide midler - Google Patents

Endoparasiticide midler

Info

Publication number
DK1259250T3
DK1259250T3 DK01911623T DK01911623T DK1259250T3 DK 1259250 T3 DK1259250 T3 DK 1259250T3 DK 01911623 T DK01911623 T DK 01911623T DK 01911623 T DK01911623 T DK 01911623T DK 1259250 T3 DK1259250 T3 DK 1259250T3
Authority
DK
Denmark
Prior art keywords
endoparasitic agents
endoparasitic
agents
Prior art date
Application number
DK01911623T
Other languages
Danish (da)
English (en)
Inventor
Jochen Kalbe
Achim Harder
Norbert Mencke
Michael Traeubel
Samson-Himmelstjerna Georg Von
Michael Stegemann
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Application granted granted Critical
Publication of DK1259250T3 publication Critical patent/DK1259250T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15Depsipeptides; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017Non-human animal skin, e.g. pour-on, spot-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK01911623T 2000-02-22 2001-02-09 Endoparasiticide midler DK1259250T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10008128A DE10008128A1 (de) 2000-02-22 2000-02-22 Endoparasitizide Mittel
PCT/EP2001/001392 WO2001062268A1 (de) 2000-02-22 2001-02-09 Endoparasitizide mittel

Publications (1)

Publication Number Publication Date
DK1259250T3 true DK1259250T3 (da) 2007-02-26

Family

ID=7631886

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01911623T DK1259250T3 (da) 2000-02-22 2001-02-09 Endoparasiticide midler

Country Status (25)

Country Link
US (1) US20030125244A1 (https=)
EP (1) EP1259250B1 (https=)
JP (2) JP5596249B2 (https=)
KR (1) KR100755414B1 (https=)
CN (1) CN1309415C (https=)
AR (2) AR028218A1 (https=)
AT (1) ATE343394T1 (https=)
AU (2) AU4060501A (https=)
BR (1) BR0108562B1 (https=)
CA (1) CA2400610C (https=)
CZ (1) CZ300242B6 (https=)
DE (2) DE10008128A1 (https=)
DK (1) DK1259250T3 (https=)
ES (1) ES2274871T3 (https=)
HK (1) HK1054326B (https=)
HU (1) HUP0204554A3 (https=)
IL (2) IL150988A0 (https=)
MX (1) MXPA02008210A (https=)
NO (1) NO328949B1 (https=)
NZ (1) NZ520856A (https=)
PL (1) PL203999B1 (https=)
PT (1) PT1259250E (https=)
RU (1) RU2292905C2 (https=)
WO (1) WO2001062268A1 (https=)
ZA (1) ZA200205982B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10104362A1 (de) * 2001-02-01 2002-08-08 Bayer Ag Kristallmodifikation eines cyclischen Depsipeptids mit besserer Wirksamkeit
DE60230686D1 (de) * 2002-11-12 2009-02-12 Kitasato Inst Anthelmintische substanz fki-1033 und verfahren zur herstellung davon
DE10358525A1 (de) 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
AU2009286380B2 (en) 2008-08-28 2011-09-15 Pfizer Inc. Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
CN107835818B (zh) 2015-05-20 2022-04-29 勃林格殷格翰动物保健美国公司 驱虫缩酚酸肽化合物
BR112018013369A2 (pt) 2015-12-28 2019-02-19 Merial, Inc. compostos depsipeptídicos anti-helmínticos
EP3541789A1 (en) 2016-11-16 2019-09-25 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
UA128873C2 (uk) 2019-08-14 2024-11-13 Ветокінол Са Композиції, що містять тиголанер, для боротьби з паразитами

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531545A1 (de) * 1985-09-04 1987-03-05 Goedecke Ag Arzneimittel mit einem gehalt an calcium-antagonisten und deren verwendung
DE3705227A1 (de) * 1987-02-19 1988-09-01 Bayer Ag Anthelminthische wirkstoffkombinationen
NZ249588A (en) * 1992-03-17 1996-08-27 Fujisawa Pharmaceutical Co Anthelmintic agent
DE4317458A1 (de) * 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
DE4309830C1 (de) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Wirkstoffpflaster für die Abgabe von Estradiol an die Haut
DE4317457A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317432A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
WO1995021624A1 (en) * 1994-02-08 1995-08-17 Nippon Kayaku Kabushiki Kaisha High-concentration aureobasidin preparation in solution form
DE4417742A1 (de) * 1994-05-20 1995-11-23 Bayer Ag Nicht-systemische Bekämpfung von Parasiten
DE19520275A1 (de) * 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
DE19545044A1 (de) * 1995-12-02 1997-06-05 Bayer Ag Endoparasitizide Mittel
GB9803448D0 (en) * 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
WO1999047139A1 (en) * 1998-03-19 1999-09-23 Merck & Co., Inc. Sulfurpenta fluorophenyl pyrazoles for controlling ectoparasitic infestations
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
DE19921887A1 (de) * 1999-05-12 2000-11-16 Bayer Ag Endoparasitizide Mittel

Also Published As

Publication number Publication date
CZ20022867A3 (cs) 2003-01-15
NO20023976D0 (no) 2002-08-21
AU4060501A (en) 2001-09-03
NZ520856A (en) 2005-04-29
IL150988A0 (en) 2003-02-12
HK1054326A1 (en) 2003-11-28
CN1309415C (zh) 2007-04-11
KR20020072577A (ko) 2002-09-16
RU2002125493A (ru) 2004-03-20
JP2012107024A (ja) 2012-06-07
ES2274871T3 (es) 2007-06-01
CA2400610C (en) 2013-01-22
HK1054326B (zh) 2007-11-09
NO328949B1 (no) 2010-06-28
DE10008128A1 (de) 2001-08-23
ZA200205982B (en) 2003-07-28
KR100755414B1 (ko) 2007-09-04
CA2400610A1 (en) 2001-08-30
EP1259250B1 (de) 2006-10-25
HUP0204554A2 (en) 2003-05-28
IL150988A (en) 2011-06-30
JP5596249B2 (ja) 2014-09-24
AR085989A2 (es) 2013-11-13
EP1259250A1 (de) 2002-11-27
NO20023976L (no) 2002-10-21
RU2292905C2 (ru) 2007-02-10
DE50111315D1 (de) 2006-12-07
WO2001062268A1 (de) 2001-08-30
ATE343394T1 (de) 2006-11-15
US20030125244A1 (en) 2003-07-03
PT1259250E (pt) 2007-01-31
AR028218A1 (es) 2003-04-30
JP2003523397A (ja) 2003-08-05
CZ300242B6 (cs) 2009-03-25
CN1404397A (zh) 2003-03-19
PL203999B1 (pl) 2009-11-30
PL357551A1 (en) 2004-07-26
HUP0204554A3 (en) 2005-05-30
AU2001240605B2 (en) 2005-04-21
MXPA02008210A (es) 2003-01-28
BR0108562B1 (pt) 2013-03-05
BR0108562A (pt) 2002-11-12

Similar Documents

Publication Publication Date Title
DK1309591T3 (da) Substituerede pyrazoler
CY1104912T1 (el) Υποκατεστημενα πυραζολια
DZ3409A1 (fr) Association therapeuthique
NO20030472L (no) Imidazolderivater
DE60133295D1 (de) Sulphoniumsalz-verbindung
NO20031869D0 (no) Antiinflammatoriske midler
DE60104308D1 (de) Rekonfigurationsverwalter
FI20002644L (fi) Liitäntäalusta
DE60107598D1 (de) Smart-skin strukturen
EE05197B1 (et) Linesoliid - kristallivorm II
DE60102473D1 (de) Indolochinazolinone
ATE298751T1 (de) 7-oxopyridoryrimidine
DE60103268D1 (de) Hochdruckumformspülanlage
EP1312379A4 (en) FIBRINOGENING AGENTS
DE60101130D1 (de) Düftungsgerät
DK1303499T3 (da) Tetrazolderivater
PT1303188E (pt) Agentes herbicidas
DK1259250T3 (da) Endoparasiticide midler
NO20024860D0 (no) Hårpleiesammensetninger
DE60129224D1 (de) Tetrazolderivate
DE10085445T1 (de) Drahterodierbearbeitungseinrichtung
DE50112951D1 (de) Gassicherheitsabsperrventil
FI20002525A7 (fi) Tulehduksenvastaisia aineita
ATE305217T1 (de) Ortho-phenylphenolat-konzentrate
DE50010192D1 (de) Intaglio-druckmaschine